NetScientific PLC (AIM:NSCI), the investment group specialising in deep tech and life sciences, said it "significantly advanced" its strategic goals last year as it provided a comprehensive update on progress and what's to come in 2024.
It revealed a portfolio expansion to 23 companies, including EMV Capital. It expects a modest increase in the fair value of its privately held assets compared to the previous year. In total, £52.2 million was raised through equity and venture debt by 13 companies within its portfolio.
Azerbaijan-based Anglo Asian Mining PLC (AIM:AAZ, OTC:AGXKF) said it has as established a Sustainability Committee, to be chaired by John Monhemius.
The committee is part of a commitment to responsible mining practices said the gold and copper miner and will oversee the development of strategy and activities related to sustainable development and social responsibility.
Faron Pharmaceuticals Limited (AIM:FARN) said the "excellent data" from its BEXMAB trial of cancer drug bexmarilimab has "intensified numerous ongoing partnering discussions", which it will advance over the coming year.
The trial was particularly significant as it targeted a patient group with MDS, an aggressive form of leukaemia that typically has limited treatment options. The early cohort comprised 10 and was split into two: higher-risk frontline MDS patients and those who had failed to respond to hypomethylating agents (HMAs).
Quantum Blockchain Technologies PLC (AIM:QBT) (QBT) has announced numerous advancements in its research and development activities in the development of its disruptive Bitcoin mining technologies.
QBT has brought ‘Method C’ to the table, a novel approach leveraging machine learning and artificial intelligence oracle technology.